Guilbault Capital’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.08M Sell
21,022
-2,438
-10% -$124K 1.06% 24
2026
Q2
$849K Buy
23,460
+235
+1% +$6.89K 0.85% 28
2026
Q1
$573K Hold
23,225
– – 0.63% 37
2025
Q4
$393K Buy
+23,225
New +$409K 0.44% 44

Other funds holding ETON

Guilbault Capital's ETON Position: Q3 2026 in Review

Guilbault Capital reduced its Eton Pharmaceutcials (ETON) stake by 10% in Q3 2026, selling an estimated $124K and leaving 21,022 shares worth $1.08M. The position accounts for 1.06% of the portfolio, ranked #24.

Guilbault Capital first reported a position in ETON in Q4 2025 and has held it in 4 quarters since. 214 funds tracked by Wall St. Rank hold ETON as of Q3 2026.

  • Guilbault Capital held 21,022 shares of Eton Pharmaceutcials worth $1.08M as of Q3 2026.
  • Guilbault Capital sold 2,438 Eton Pharmaceutcials shares in Q3 2026, an estimated $124K.
  • Eton Pharmaceutcials made up 1.06% of Guilbault Capital's portfolio in Q3 2026, its #24 holding.
  • Guilbault Capital first reported a position in Eton Pharmaceutcials in Q4 2025 and has held it in 4 quarters since.
  • 214 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.

Based on Guilbault Capital's 13F filing for Q3 2026, filed 28 Oct 2026.